1. Medtech Insight

Abbott Diagnostics Quality System Violations Require Outside Audit By August

Abbott's pending sale of its diagnostics business to GE will not be affected by an FDA warning letter citing quality control problems at its Irving, Texas, plant, the company claims

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Medtech Insight